Aptus Capital Advisors’s Alpha Tau Medical DRTS Stock Holding History

Aptus Capital Advisors’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Hold	20,000	–	–	﹤0.01%	1016
2026 Q1	$141K	Sell	20,000 -1,945	-9%	-$13.7K	﹤0.01%	1075
2025 Q4	$109K	Hold	21,945	–	–	﹤0.01%	1162
2025 Q3	$99K	Hold	21,945	–	–	﹤0.01%	1123
2025 Q2	$68.5K	Hold	21,945	–	–	﹤0.01%	1132
2025 Q1	$55.1K	Hold	21,945	–	–	﹤0.01%	1096
2024 Q4	$68K	Hold	21,945	–	–	﹤0.01%	1063
2024 Q3	$52.2K	Hold	21,945	–	–	﹤0.01%	931
2024 Q2	$55.5K	Buy	21,945 +10,000	+84%	+$25.4K	﹤0.01%	880
2024 Q1	$35.2K	Buy	+11,945	New	+$36.7K	﹤0.01%	926

Other funds holding DRTS

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Aptus Capital Advisors's DRTS Position: Q2 2026 in Review

Aptus Capital Advisors held its Alpha Tau Medical (DRTS) position steady in Q2 2026 at 20,000 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Aptus Capital Advisors first reported a position in DRTS in Q1 2024 and has held it in 10 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

Aptus Capital Advisors held 20,000 shares of Alpha Tau Medical worth $252K as of Q2 2026.
Aptus Capital Advisors left its Alpha Tau Medical share count unchanged in Q2 2026.
Alpha Tau Medical made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1016 holding.
Aptus Capital Advisors first reported a position in Alpha Tau Medical in Q1 2024 and has held it in 10 quarters since.
74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.